To investigate CAIX/XII expression in tumor tissues on a protein level, we employed our established preclinical CRC model comprising luciferase-expressing cell-line-derived nude mouse xenograft tumors and spheroids representing the four molecular subtypes according to the CMS classification system. The gene discussed is CA9; the disease is colorectal carcinoma.